Clinical Trials Browser

Fluorodeoxyglucose F18 × Plasma cell × Clear all

NCT07463807 2026-03-18

Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment

Phase 1/2 Not yet recruiting

Multiple Myeloma

NCT06385652 2026-01-06

PET Imaging Study of 68Ga-NB381 in Multiple Myeloma

Phase EARLY_PHASE1 Recruiting

Multiple Myeloma

NCT05892393 2025-11-12

Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

Phase 1 Recruiting

Multiple Myeloma

NCT06717113 2025-06-06

A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma

Phase EARLY_PHASE1 Recruiting

Multiple Myeloma

NCT05950113 2024-05-01

CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1 Withdrawn

Multiple Myeloma

NCT04349358 2023-10-17

MIM

Phase NA Recruiting

Nuchal bleb, familial, Multiple Myeloma

NCT05448404 2022-07-08

A Head-to-head Comparative Study of 18F-PSMA-1007 PET/CT and 18F-FDG PET/CT Imaging in Multiple Myeloma

Phase NA Unknown

Multiple Myeloma